The addition to the IABP family supports uncompromised cardiac support for patients during transportWAYNE, Pa., April 01, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global ...
Based on the advice from the FDA at the meeting, Connect plans to begin enrolling patients in these trials during the second quarter of this year.
It's not yet been a week since Marty Makary, M.D., was confirmed to lead the FDA as its commissioner. | Peter Marks, M.D., Ph ...
We are very happy to have been granted a meeting with the FDA to review the positive OnTarget results in breast cancer patients and our goal is to discuss the most efficient pathways to make ...
The Senate voted Tuesday to confirm the heads of two major federal health agencies. Jay Bhattacharya, MD, PhD, will become ...
Q4 2024 Earnings Call Transcript March 27, 2025 PDS Biotechnology Corporation beats earnings expectations. Reported EPS is ...
The FDA highlighted two key Chemistry, Manufacturing and Controls issues to be addressed. "Our team is evaluating the feedback provided and intends to request a Type A meeting to discuss the ...
Jaguar Health (JAGX) announced that the U.S. Food and Drug Administration has granted Napo a Type C Meeting in the second quarter of 2025 to ...
Additional data from the MDNA11 ABILITY-1 trial to be presented at the Annual Meeting. Pre-clinical data on Medicenna's first-in-class Masked and Tumor Targeted Bifunctional anti- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback